The latest report suggests that TAM and tumor monocytes are the main sources of IL-1β in human pancreatic ductal adenocarcinoma, which is closely related to the malignant progression of human pancreatic ductal adenocarcinoma and the poor prognosis of patients [27]. Here, IL1B is linked to pancreatic ductal adenocarcinoma.